Global and United States CAR T-Cell Immunotherapy Market Report & Forecast 2023-2028

Report ID: 1873715 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 CAR T-Cell Immunotherapy Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Introduction
    1.2 Global CAR T-Cell Immunotherapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global CAR T-Cell Immunotherapy Market Size for the Year 2017-2028
        1.2.2 Global CAR T-Cell Immunotherapy Market Size for the Year 2017-2028
    1.3 CAR T-Cell Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States CAR T-Cell Immunotherapy in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of CAR T-Cell Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 CAR T-Cell Immunotherapy Market Dynamics
        1.4.1 CAR T-Cell Immunotherapy Industry Trends
        1.4.2 CAR T-Cell Immunotherapy Market Drivers
        1.4.3 CAR T-Cell Immunotherapy Market Challenges
        1.4.4 CAR T-Cell Immunotherapy Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 CAR T-Cell Immunotherapy by Type
    2.1 CAR T-Cell Immunotherapy Market Segment by Type
        2.1.1 Monotherapy
        2.1.2 Combination Therapy
    2.2 Global CAR T-Cell Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.3 Global CAR T-Cell Immunotherapy Market Size by Type (2017-2028)
    2.4 United States CAR T-Cell Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.5 United States CAR T-Cell Immunotherapy Market Size by Type (2017-2028)
3 CAR T-Cell Immunotherapy by Application
    3.1 CAR T-Cell Immunotherapy Market Segment by Application
        3.1.1 Hematologic Malignancies
        3.1.2 Solid Malignancies
    3.2 Global CAR T-Cell Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.3 Global CAR T-Cell Immunotherapy Market Size by Application (2017-2028)
    3.4 United States CAR T-Cell Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.5 United States CAR T-Cell Immunotherapy Market Size by Application (2017-2028)
4 Global CAR T-Cell Immunotherapy Competitor Landscape by Company
    4.1 Global CAR T-Cell Immunotherapy Market Size by Company
        4.1.1 Top Global CAR T-Cell Immunotherapy Companies Ranked by Revenue (2021)
        4.1.2 Global CAR T-Cell Immunotherapy Revenue by Player (2017-2022)
    4.2 Global CAR T-Cell Immunotherapy Concentration Ratio (CR)
        4.2.1 CAR T-Cell Immunotherapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of CAR T-Cell Immunotherapy in 2021
        4.2.3 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global CAR T-Cell Immunotherapy Headquarters, Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.1 Global CAR T-Cell Immunotherapy Headquarters and Area Served
        4.3.2 Global CAR T-Cell Immunotherapy Companies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into CAR T-Cell Immunotherapy Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States CAR T-Cell Immunotherapy Market Size by Company
        4.5.1 Top CAR T-Cell Immunotherapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States CAR T-Cell Immunotherapy Revenue by Players (2020, 2021 & 2022)
5 Global CAR T-Cell Immunotherapy Market Size by Region
    5.1 Global CAR T-Cell Immunotherapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global CAR T-Cell Immunotherapy Market Size by Region (2017-2028)
        5.2.1 Global CAR T-Cell Immunotherapy Market Size by Region: 2017-2022
        5.2.2 Global CAR T-Cell Immunotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America CAR T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.1.2 North America CAR T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific CAR T-Cell Immunotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe CAR T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.3.2 Europe CAR T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America CAR T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America CAR T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa CAR T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa CAR T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AbbVie
        7.1.1 AbbVie Company Details
        7.1.2 AbbVie Business Overview
        7.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
        7.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.1.5 AbbVie Recent Development
    7.2 Celgene
        7.2.1 Celgene Company Details
        7.2.2 Celgene Business Overview
        7.2.3 Celgene CAR T-Cell Immunotherapy Introduction
        7.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.2.5 Celgene Recent Development
    7.3 Kite Pharma
        7.3.1 Kite Pharma Company Details
        7.3.2 Kite Pharma Business Overview
        7.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
        7.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.3.5 Kite Pharma Recent Development
    7.4 Oxford BioMedica
        7.4.1 Oxford BioMedica Company Details
        7.4.2 Oxford BioMedica Business Overview
        7.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
        7.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.4.5 Oxford BioMedica Recent Development
    7.5 Novartis
        7.5.1 Novartis Company Details
        7.5.2 Novartis Business Overview
        7.5.3 Novartis CAR T-Cell Immunotherapy Introduction
        7.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.5.5 Novartis Recent Development
    7.6 Gilead
        7.6.1 Gilead Company Details
        7.6.2 Gilead Business Overview
        7.6.3 Gilead CAR T-Cell Immunotherapy Introduction
        7.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.6.5 Gilead Recent Development
    7.7 Pfizer
        7.7.1 Pfizer Company Details
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
        7.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.7.5 Pfizer Recent Development
    7.8 Cellectis
        7.8.1 Cellectis Company Details
        7.8.2 Cellectis Business Overview
        7.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
        7.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.8.5 Cellectis Recent Development
    7.9 Bellicum
        7.9.1 Bellicum Company Details
        7.9.2 Bellicum Business Overview
        7.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
        7.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.9.5 Bellicum Recent Development
    7.10 Mustang Bio
        7.10.1 Mustang Bio Company Details
        7.10.2 Mustang Bio Business Overview
        7.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
        7.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.10.5 Mustang Bio Recent Development
    7.11 CARsgen Therapeutics
        7.11.1 CARsgen Therapeutics Company Details
        7.11.2 CARsgen Therapeutics Business Overview
        7.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
        7.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.11.5 CARsgen Therapeutics Recent Development
    7.12 Xyphos
        7.12.1 Xyphos Company Details
        7.12.2 Xyphos Business Overview
        7.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
        7.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.12.5 Xyphos Recent Development
    7.13 Minerva Biotechnologies
        7.13.1 Minerva Biotechnologies Company Details
        7.13.2 Minerva Biotechnologies Business Overview
        7.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
        7.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.13.5 Minerva Biotechnologies Recent Development
    7.14 Adaptimmune
        7.14.1 Adaptimmune Company Details
        7.14.2 Adaptimmune Business Overview
        7.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
        7.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.14.5 Adaptimmune Recent Development
    7.15 Ziopharm Oncology
        7.15.1 Ziopharm Oncology Company Details
        7.15.2 Ziopharm Oncology Business Overview
        7.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
        7.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.15.5 Ziopharm Oncology Recent Development
    7.16 Aurora Biopharma
        7.16.1 Aurora Biopharma Company Details
        7.16.2 Aurora Biopharma Business Overview
        7.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
        7.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.16.5 Aurora Biopharma Recent Development
    7.17 Creative Biolabs
        7.17.1 Creative Biolabs Company Details
        7.17.2 Creative Biolabs Business Overview
        7.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
        7.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022)
        7.17.5 Creative Biolabs Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. CAR T-Cell Immunotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. CAR T-Cell Immunotherapy Market Trends
    Table 3. CAR T-Cell Immunotherapy Market Drivers
    Table 4. CAR T-Cell Immunotherapy Market Challenges
    Table 5. CAR T-Cell Immunotherapy Market Restraints
    Table 6. Global CAR T-Cell Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States CAR T-Cell Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global CAR T-Cell Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States CAR T-Cell Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top CAR T-Cell Immunotherapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global CAR T-Cell Immunotherapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global CAR T-Cell Immunotherapy Revenue Share by Player, 2017-2022
    Table 13. Global CAR T-Cell Immunotherapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global CAR T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2021)
    Table 15. Top Players of CAR T-Cell Immunotherapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into CAR T-Cell Immunotherapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top CAR T-Cell Immunotherapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States CAR T-Cell Immunotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States CAR T-Cell Immunotherapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global CAR T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global CAR T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global CAR T-Cell Immunotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America CAR T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific CAR T-Cell Immunotherapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe CAR T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa CAR T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa CAR T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AbbVie Company Details
    Table 31. AbbVie Business Overview
    Table 32. AbbVie CAR T-Cell Immunotherapy Product
    Table 33. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 34. AbbVie Recent Development
    Table 35. Celgene Company Details
    Table 36. Celgene Business Overview
    Table 37. Celgene CAR T-Cell Immunotherapy Product
    Table 38. Celgene Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 39. Celgene Recent Development
    Table 40. Kite Pharma Company Details
    Table 41. Kite Pharma Business Overview
    Table 42. Kite Pharma CAR T-Cell Immunotherapy Product
    Table 43. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 44. Kite Pharma Recent Development
    Table 45. Oxford BioMedica Company Details
    Table 46. Oxford BioMedica Business Overview
    Table 47. Oxford BioMedica CAR T-Cell Immunotherapy Product
    Table 48. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 49. Oxford BioMedica Recent Development
    Table 50. Novartis Company Details
    Table 51. Novartis Business Overview
    Table 52. Novartis CAR T-Cell Immunotherapy Product
    Table 53. Novartis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 54. Novartis Recent Development
    Table 55. Gilead Company Details
    Table 56. Gilead Business Overview
    Table 57. Gilead CAR T-Cell Immunotherapy Product
    Table 58. Gilead Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 59. Gilead Recent Development
    Table 60. Pfizer Company Details
    Table 61. Pfizer Business Overview
    Table 62. Pfizer CAR T-Cell Immunotherapy Product
    Table 63. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 64. Pfizer Recent Development
    Table 65. Cellectis Company Details
    Table 66. Cellectis Business Overview
    Table 67. Cellectis CAR T-Cell Immunotherapy Product
    Table 68. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 69. Cellectis Recent Development
    Table 70. Bellicum Company Details
    Table 71. Bellicum Business Overview
    Table 72. Bellicum CAR T-Cell Immunotherapy Product
    Table 73. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 74. Bellicum Recent Development
    Table 75. Mustang Bio Company Details
    Table 76. Mustang Bio Business Overview
    Table 77. Mustang Bio CAR T-Cell Immunotherapy Product
    Table 78. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 79. Mustang Bio Recent Development
    Table 80. CARsgen Therapeutics Company Details
    Table 81. CARsgen Therapeutics Business Overview
    Table 82. CARsgen Therapeutics CAR T-Cell Immunotherapy Product
    Table 83. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 84. CARsgen Therapeutics Recent Development
    Table 85. Xyphos Company Details
    Table 86. Xyphos Business Overview
    Table 87. Xyphos CAR T-Cell Immunotherapy Product
    Table 88. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 89. Xyphos Recent Development
    Table 90. Minerva Biotechnologies Company Details
    Table 91. Minerva Biotechnologies Business Overview
    Table 92. Minerva Biotechnologies CAR T-Cell Immunotherapy Product
    Table 93. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 94. Minerva Biotechnologies Recent Development
    Table 95. Adaptimmune Company Details
    Table 96. Adaptimmune Business Overview
    Table 97. Adaptimmune CAR T-Cell Immunotherapy Product
    Table 98. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 99. Adaptimmune Recent Development
    Table 100. Ziopharm Oncology Company Details
    Table 101. Ziopharm Oncology Business Overview
    Table 102. Ziopharm Oncology CAR T-Cell Immunotherapy Product
    Table 103. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 104. Ziopharm Oncology Recent Development
    Table 105. Aurora Biopharma Company Details
    Table 106. Aurora Biopharma Business Overview
    Table 107. Aurora Biopharma CAR T-Cell Immunotherapy Product
    Table 108. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 109. Aurora Biopharma Recent Development
    Table 110. Creative Biolabs Company Details
    Table 111. Creative Biolabs Business Overview
    Table 112. Creative Biolabs CAR T-Cell Immunotherapy Product
    Table 113. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 114. Creative Biolabs Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. CAR T-Cell Immunotherapy Product Picture
    Figure 2. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global CAR T-Cell Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States CAR T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States CAR T-Cell Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States CAR T-Cell Immunotherapy Market Share in Global 2017-2028
    Figure 7. CAR T-Cell Immunotherapy Report Years Considered
    Figure 8. Product Picture of Monotherapy
    Figure 9. Product Picture of Combination Therapy
    Figure 10. Global CAR T-Cell Immunotherapy Market Share by Type in 2022 & 2028
    Figure 11. Global CAR T-Cell Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    Figure 13. United States CAR T-Cell Immunotherapy Market Share by Type in 2022 & 2028
    Figure 14. United States CAR T-Cell Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States CAR T-Cell Immunotherapy Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hematologic Malignancies
    Figure 17. Product Picture of Solid Malignancies
    Figure 18. Global CAR T-Cell Immunotherapy Market Share by Application in 2022 & 2028
    Figure 19. Global CAR T-Cell Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    Figure 21. United States CAR T-Cell Immunotherapy Market Share by Application in 2022 & 2028
    Figure 22. United States CAR T-Cell Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States CAR T-Cell Immunotherapy Market Share by Application (2017-2028)
    Figure 24. North America CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E CAR T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 53. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 54. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 55. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 57. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 59. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 60. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 61. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 62. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 63. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 64. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 65. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 66. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 67. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 68. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Frequently Asked Questions
CAR T-Cell Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CAR T-Cell Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CAR T-Cell Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Papaya Pulp & Puree

Papaya Pulp & Puree market is segmented by region (country), players, by Type and by Application. ... Read More

Banana Pulp

Banana Pulp market is segmented by region (country), players, by Type and by Application. Players ... Read More